SciELO - Scientific Electronic Library Online

 
vol.92 número4Placas máculonoduliformes hiperpigmentadas pruriginosas en niño de dos años de edadSífilis secundaria de recidiva: A propósito de un caso índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista argentina de dermatología

versión On-line ISSN 1851-300X

Resumen

PALOMBO, M  y  ACHENBACH, RE. Fabry disease: Report of eight cases. Rev. argent. dermatol. [online]. 2011, vol.92, n.4, pp.18-45. ISSN 1851-300X.

Fabry disease (Online Mendelian Inheritance in Man No. 301500) is an X-linked inherited condition due to absence or reduction of ɑ galactosidase activity in lysosomes that results in accumulation of globotriaosylceramide and related neutral glycosphingolipids (storage disorder). It is estimated to occur in 1 in 40.000 to 117.000 live male births, although a more recent screening study in newborns suggests a much higher incidence. The main clinical traits include cutaneous lesions (angiokeratomas), progressive renal damage with proteinuria, painful neuropathy predominantly affecting the hands and feet (acroparesthesias), myocardial hypertrophy, gastrointestinal manifestations, corneal dystrophy and hypohidrosis. This entails severe progressive multi-system involvement leading to premature death. More than 600 mutations have been described worldwide most of which are private or particular mutations of a single family. We report a 28 years-old woman who consulted to one of us and since 2010 eight cases of the same family were studied and treated with support and enzyme replacement therapy in order to delay the damage to the end organ.

Palabras clave : Angiokeratomas; Enzyme replacement therapy; Eigth cases.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons